Drug Type Small molecule drug |
Synonyms MT 125, MT125 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Myosin Therapeutics, Inc.Startup |
Active Organization Myosin Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | Myosin Therapeutics, Inc.Startup | 14 Apr 2023 |